Trending

GENSCO® TRENDING

Gensco® Pharma Partners with IntelGenx to Market RIZAPORT® in the United States December 12, 2018 Featured, Industry, Press Release, Product Update - Miami, Florida, December 12, 2018 – Gensco® Pharma, a leading specialty pharmaceutical manufacturer specializing in development and commercialization of prescription transdermal products, today announced the execution of a definitive licensing, development and supply agreement (the “Agreement”) with IntelGenx Corp (TSX-V: IGX) (OTCQX: IGXT) (“IntelGenx”), a leading oral drug delivery company, more...

LOOKING TO THE FUTURE

A single dose topical colchinium for acute gout flares.

 

Click here for all trending items